Bangkok Dusit Medical Stock Shares Owned By Insiders
| BDMS-R Stock | THB 26.75 1.25 4.46% |
Bangkok Dusit Medical fundamentals help investors to digest information that contributes to Bangkok Dusit's financial success or failures. It also enables traders to predict the movement of Bangkok Stock. The fundamental analysis module provides a way to measure Bangkok Dusit's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bangkok Dusit stock.
Bangkok |
Bangkok Dusit Medical Company Shares Owned By Insiders Analysis
Bangkok Dusit's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Bangkok Dusit Shares Owned By Insiders | 2.30 % |
Most of Bangkok Dusit's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bangkok Dusit Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 2.3% of Bangkok Dusit Medical are shares owned by insiders. This is 84.85% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The shares owned by insiders for all Thailand stocks is 77.21% higher than that of the company.
Bangkok Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bangkok Dusit's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bangkok Dusit could also be used in its relative valuation, which is a method of valuing Bangkok Dusit by comparing valuation metrics of similar companies.Bangkok Dusit is currently under evaluation in shares owned by insiders category among its peers.
Bangkok Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0739 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 454.24 B | |||
| Shares Outstanding | 15.89 B | |||
| Shares Owned By Insiders | 2.30 % | |||
| Shares Owned By Institutions | 5.23 % | |||
| Price To Earning | 42.31 X | |||
| Price To Book | 5.54 X | |||
| Price To Sales | 4.94 X | |||
| Revenue | 74.45 B | |||
| Gross Profit | 24.99 B | |||
| EBITDA | 17.64 B | |||
| Net Income | 7.94 B | |||
| Cash And Equivalents | 5.01 B | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 12.5 B | |||
| Debt To Equity | 0.57 % | |||
| Current Ratio | 0.79 X | |||
| Book Value Per Share | 5.41 X | |||
| Cash Flow From Operations | 14.56 B | |||
| Earnings Per Share | 0.77 X | |||
| Number Of Employees | 10 | |||
| Beta | 0.43 | |||
| Market Capitalization | 460.87 B | |||
| Total Asset | 128.45 B | |||
| Retained Earnings | 28.38 B | |||
| Working Capital | (3.49 B) | |||
| Current Asset | 12.76 B | |||
| Current Liabilities | 16.25 B | |||
| Z Score | 21.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 128.45 B | |||
| Last Dividend Paid | 0.5 |
About Bangkok Dusit Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bangkok Dusit Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bangkok Dusit using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bangkok Dusit Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bangkok Stock
Bangkok Dusit financial ratios help investors to determine whether Bangkok Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bangkok with respect to the benefits of owning Bangkok Dusit security.